Treatment of Progressive MS: Why, Who, When, How
Giancarlo Comi, MD
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Prof. Ralf Gold
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Diagnostic Challenges of Spinal Cord Lesions in MS
Jiwon Oh, MD, PhD
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Reducing the Burden of MS Treatment
Multiple Sclerosis Physician Resources
Highlights from the MAGNIMS Consensus Guidelines
Optimizing MS Treatment Options
Immunologic Effects on Metabolic Syndrome and MS
Current and Future MS Treatment Options
Determining an MS Patient's Long-Term Prognosis
Emerging MRI Techniques in MS Patients
Current Landscape of MS Diagnosis/Prognosis
The Value of Biomarkers in MS Patients
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.